Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

NCT06706466 · clinicaltrials.gov ↗

COMPLETED

Status

410

Enrollment

OTHER

Sponsor class

Conditions

Immunotherapy Gastrict Cancer
Inflammation Biomarkers
Gastric Cancers

Interventions

OTHER: observational study

Sponsor

Chang-Ming Huang, Prof.